Cargando…
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
Over a half century, organ transplantation has become an effective method for the treatment of end-stage visceral diseases. Although the application of immunosuppressants (IS) minimizes the rate of allograft rejection, the common use of IS bring many adverse effects to transplant patients. Moreover,...
Autores principales: | Zhuang, Quan, Cai, Haozheng, Cao, Qingtai, Li, Zixin, Liu, Shu, Ming, Yingzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573100/ https://www.ncbi.nlm.nih.gov/pubmed/33123131 http://dx.doi.org/10.3389/fimmu.2020.552988 |
Ejemplares similares
-
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018) -
Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019) -
Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials
por: Moreau, Aurélie, et al.
Publicado: (2012) -
Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013) -
Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)